Trials / Unknown
UnknownNCT00690950
A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart
Switch Study: Are There Any Measurable Differences When Switching Patients on Finasteride Therapy to Dutasteride?
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Urologic Consultants of Southeastern PA · Academic / Other
- Sex
- Male
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Dutasteride will perform better than finasteride in decreasing prostate volume, improving symptoms based on International Prostate Symptom score,and lower pvr based on the scientific information that dutasteride inhibits both Type I and II 5-alpha-reducatase vs. finasteride which only inhibits the Type II enzyme
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dutasteride | 0.5mg capsule, taken once daily for 12 months |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-07-01
- First posted
- 2008-06-05
- Last updated
- 2008-06-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00690950. Inclusion in this directory is not an endorsement.